Clinical Trial Update: Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for anti-CD19 CAR T-cell therapy being explored in refractory systemic autoimmune diseases, including systemic lupus erythematosus, system…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Dermatomyositis
• Polymyositis
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• CD19-directed CAR-T cell therapy

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Lupus Erythematosus, Systemic, System; Sclerosis | Phase 1, Phase 2 | Status: RECRUITING